All Stories

  1. Targeting myeloid-derived suppressor cells in the treatment of hepatocellular carcinoma: current state and future perspectives
  2. Targeting tumor-infiltrating Ly6G+ myeloid cells improves sorafenib efficacy in mouse orthotopic hepatocellular carcinoma